HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 50 filers reported holding HAEMONETICS CORP MASS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $141,345 | +1.9% | 162,000 | 0.0% | 0.00% | – |
Q2 2023 | $138,655 | +0.3% | 162,000 | 0.0% | 0.00% | – |
Q1 2023 | $138,264 | +68.0% | 162,000 | +63.6% | 0.00% | – |
Q4 2022 | $82,299 | -13.4% | 99,000 | -16.8% | 0.00% | – |
Q3 2022 | $95,000 | +1.1% | 119,000 | 0.0% | 0.00% | – |
Q2 2022 | $94,000 | – | 119,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 18,000,000 | $15,705,000 | 1.15% |
Context Capital Management, LLC | 14,558 | $12,660 | 1.02% |
Quaero Capital S.A. | 1,200,000 | $1,042,440 | 0.99% |
READYSTATE ASSET MANAGEMENT LP | 22,200,000 | $19,369,500 | 0.97% |
DeepCurrents Investment Group LLC | 24,371,000 | $21,212,517 | 0.92% |
ADVENT CAPITAL MANAGEMENT /DE/ | 39,904,000 | $34,816,240 | 0.81% |
SSI INVESTMENT MANAGEMENT LLC | 10,872,000 | $9,431,462 | 0.77% |
Empyrean Capital Partners, LP | 13,500,000 | $11,696,959 | 0.72% |
MACKAY SHIELDS LLC | 29,294,000 | $25,825,110 | 0.71% |
Aequim Alternative Investments LP | 20,500,000 | $17,886,250 | 0.68% |